EBACU

European Biotech Acquisition Corp. Units
EBACU

Delisted

EBACU was delisted on the 2nd of March, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in European Biotech Acquisition Corp. Units in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 11 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
–
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1
-$2.01M
2
-$1.78M
3
-$1.47M
4
HF
HRT Financial
New York
-$755K
5
Walleye Capital
Walleye Capital
New York
-$733K
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
1
Millennium Management
New York
–
Bank of Montreal
2
Bank of Montreal
Ontario, Canada
–
Jane Street
3
Jane Street
New York
–
HF
4
HRT Financial
New York
–
Walleye Capital
5
Walleye Capital
New York
–
Walleye Trading
6
Walleye Trading
New York
–
CSS
7
Cubist Systematic Strategies
Connecticut
–
LCM
8
Landscape Capital Management
New Jersey
–
CS
9
Clear Street
New York
–
TAM
10
Terrapin Asset Management
Florida
–
DCM
11
Dupont Capital Management
Delaware
–